Immune checkpoint blockade in triple negative breast cancer influenced by B cells through myeloid-derived suppressor cells
Vito et al. investigated the effects of combination therapy in a TNBC tumor model and reported increased tumor-infiltrating lymphocytes that contributed to an improved response to immune checkpoint blockade. By depletion of circulating B cells prior to therapy, the authors showed a loss of therapeut...
Main Authors: | Alyssa Vito, Omar Salem, Nader El-Sayes, Ian P. MacFawn, Ana L. Portillo, Katy Milne, Danielle Harrington, Ali A. Ashkar, Yonghong Wan, Samuel T. Workenhe, Brad H. Nelson, Tullia C. Bruno, Karen L. Mossman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2021-07-01
|
Series: | Communications Biology |
Online Access: | https://doi.org/10.1038/s42003-021-02375-9 |
Similar Items
-
Chemotherapy-induced recruitment of myeloid-derived suppressor cells abrogates efficacy of immune checkpoint blockade
by: Tsz Tung Kwong, et al.
Published: (2021-04-01) -
Tumor Heterogeneity: A Great Barrier in the Age of Cancer Immunotherapy
by: Nader El-Sayes, et al.
Published: (2021-02-01) -
Hypoxia-Driven Immune Escape in the Tumor Microenvironment
by: Alyssa Vito, et al.
Published: (2020-04-01) -
Rethinking immune checkpoint blockade: ‘Beyond the T cell’
by: Xiuting Liu, et al.
Published: (2021-01-01) -
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade
by: Elisa Peranzoni, et al.
Published: (2020-07-01)